Current Edition

Current features

Revolutionising Hypertension Management Through Personalised, Data-driven Dose Optimisation

In the late 1990s, Pfizer’s revenue stream was predominantly fuelled from the sales of antihypertensive drugs. The climax, so to speak, of its rigorous anti-hyperten...
Continue Reading →
Regional News

Daiichi Sankyo, with tighter focus on oncology, sells 8 aging US cardiovascular drugs to diversifying Cosette

With the acquisition of the U.S. sales and distribution rights of eight cardiovascular drugs from Daiichi Sankyo, Cosette Pharma of New Jersey is making a move toward...
Continue Reading →
Europe

Too few women take part in many CVD clinical trials

Women make up a lower than expected proportion of participants in many clinical trials for cardiovascular disease, US researchers have found. The authors of the stud...
Continue Reading →